We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$617M
AUM Growth
-$11.4M
Cap. Flow
-$20.2M
Cap. Flow %
-3.28%
Top 10 Hldgs %
40%
Holding
100
New
13
Increased
21
Reduced
32
Closed
8

Top Buys

Rank Stock Value
1
ZS icon
Zscaler
ZS
+$16.8M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$11.9M
3
ABT icon
Abbott
ABT
+$10.5M
4
AVTR icon
Avantor
AVTR
+$10.2M
5
TMO icon
Thermo Fisher Scientific
TMO
+$9.82M

Sector Composition

Rank Sector Weight
1 Technology 32.22%
2 Healthcare 25.65%
3 Financials 13.72%
4 Industrials 6.63%
5 Consumer Discretionary 6.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELF icon
51
e.l.f. Beauty
ELF
$4.56B
$3.13M 0.51%
107,800
-181,300
-63% -$5.19M
ON icon
52
ON Semiconductor
ON
$33.8B
$2.77M 0.45%
+60,500
New +$2.59M
PG icon
53
Procter & Gamble
PG
$343B
$2.51M 0.41%
17,937
+50
+0.3% +$7.09K
GIS icon
54
General Mills
GIS
$19.2B
$2.1M 0.34%
35,193
BCE icon
55
BCE
BCE
$19.9B
$2.05M 0.33%
41,000
+100
+0.2% +$5.06K
JPM icon
56
JPMorgan Chase
JPM
$939B
$1.87M 0.3%
11,400
-64,800
-85% -$10.2M
JNJ icon
57
Johnson & Johnson
JNJ
$635B
$1.8M 0.29%
11,150
SYK icon
58
Stryker
SYK
$127B
$1.75M 0.28%
6,618
-33,700
-84% -$9.01M
MAS icon
59
Masco
MAS
$16B
$1.67M 0.27%
30,134
-33
-0.1% -$1.96K
BMY icon
60
Bristol-Myers Squibb
BMY
$127B
$1.62M 0.26%
27,350
+100
+0.4% +$6.59K
LLY icon
61
Eli Lilly
LLY
$1.07T
$1.59M 0.26%
6,894
AWK icon
62
American Water Works
AWK
$26.3B
$1.48M 0.24%
8,750
ITW icon
63
Illinois Tool Works
ITW
$81.4B
$1.45M 0.23%
7,000
VZ icon
64
Verizon
VZ
$194B
$1.23M 0.2%
22,681
+300
+1% +$16.6K
HSIC icon
65
Henry Schein
HSIC
$9.74B
$1.18M 0.19%
15,430
+200
+1% +$15.4K
STE icon
66
Steris
STE
$20.9B
$1.1M 0.18%
5,400
NBIX icon
67
Neurocrine Biosciences
NBIX
$17.7B
$1.1M 0.18%
11,483
WASH icon
68
Washington Trust Bancorp
WASH
$732M
$1.02M 0.17%
19,272
-2,060
-10% -$105K
IART icon
69
Integra LifeSciences
IART
$1.54B
$1M 0.16%
14,608
AZN icon
70
AstraZeneca
AZN
$263B
$980K 0.16%
+8,159
New +$950K
HD icon
71
Home Depot
HD
$332B
$966K 0.16%
2,944
SHW icon
72
Sherwin-Williams
SHW
$78.3B
$797K 0.13%
2,850
BRK.B icon
73
Berkshire Hathaway Class B
BRK.B
$1.07T
$757K 0.12%
2,773
-69,500
-96% -$19.5M
ADP icon
74
Automatic Data Processing
ADP
$100B
$726K 0.12%
3,634
ATO icon
75
Atmos Energy
ATO
$29.9B
$710K 0.12%
8,050

Similar funds

De Burlo Group's Q3 2021 Portfolio in Review

As of Q3 2021, De Burlo Group held 100 positions worth $617M, down 1.8% from $628M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

De Burlo Group withdrew a net $20.2M in Q3 2021, closing 8 positions and reducing 32 holdings. Its most notable exit was PPG Industries, an estimated $19M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, De Burlo Group opened a new position in Zscaler worth $17.6M.

  • De Burlo Group's largest Q3 2021 buy was Zscaler: 67,100 shares worth $17.6M.
  • De Burlo Group added most to Abbott in Q3 2021, an estimated $10.5M increase.
  • De Burlo Group's biggest Q3 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $19.5M.
  • De Burlo Group fully exited PPG Industries in Q3 2021, selling an estimated $19M.
  • De Burlo Group's ten largest holdings make up 40% of its $617M portfolio in Q3 2021.
  • De Burlo Group opened 13 new positions and closed 8 in Q3 2021.
  • De Burlo Group's portfolio value fell 1.8% quarter-over-quarter to $617M.

Based on De Burlo Group's 13F filing for Q3 2021, filed 9 Nov 2021.